SCHEMBL6986432

SCHEMBL6986432

CNc1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.48
FPR1 P21462 4/20 0.43
FPR2 P25090 4/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
AVPR2 P30518 1/20 0.41
NR3C1 P04150 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977731 0.86 TP53 (0.45) TP53FPR1FPR2ALDH1A1MEN1
SCHEMBL6978505 0.86 BRD4 (0.45) TP53FPR1FPR2ALDH1A1MEN1
SCHEMBL6984731 0.86 TP53 (0.45) TP53FPR1FPR2HDAC1HDAC8
SCHEMBL6984459 0.85 FPR1 (0.44) TP53FPR1FPR2HDAC1HDAC8
SCHEMBL6976631 0.85 HSD17B3 (0.46) TP53FPR1FPR2ALDH1A1MEN1
SCHEMBL6986003 0.85 RAB9A (0.48) TP53FPR1FPR2ALDH1A1MEN1
SCHEMBL6982938 0.85 NR3C1 (0.51) TP53FPR1FPR2ALDH1A1MEN1
SCHEMBL6985377 0.84 RAB9A (0.62) TP53FPR1FPR2HDAC1HDAC8
SCHEMBL6976282 0.84 TP53 (0.44) TP53FPR1FPR2HDAC1HDAC8
SCHEMBL6979722 0.84 TP53 (0.48) TP53FPR1FPR2HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed